{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:21:04Z","timestamp":1790727664318,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.tiv.2024.105920","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T21:33:59Z","timestamp":1724362439000},"page":"105920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Unveiling the anticancer potential of Pestalotioprolide E, an unexplored macrolide: Targeting TRXR1-TRX1-ASK1-P38 signaling cascade in triple-negative breast cancer"],"prefix":"10.1016","volume":"100","author":[{"given":"Ruma","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debobrata","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayantan","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajib Kumar","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosenjit","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2024.105920_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142926","article-title":"Identification of new antifungal compounds targeting thioredoxin reductase of Paracoccidioides genus","volume":"10","author":"Abadio","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tiv.2024.105920_bb0010","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s10637-021-01106-5","article-title":"Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer","volume":"39","author":"Abdullah","year":"2021","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.tiv.2024.105920_bb0015","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","article-title":"Metastatic and triple-negative breast cancer: challenges and treatment options","volume":"8","author":"Al-Mahmood","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.tiv.2024.105920_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.redox.2015.12.004","article-title":"The thioredoxin system in breast cancer cell invasion and migration","volume":"8","author":"Bhatia","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.tiv.2024.105920_bb0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tiv.2024.105920_bb0030","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2024.105920_bb0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3322\/caac.21443","article-title":"The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment","volume":"68","author":"Carrera","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tiv.2024.105920_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1476-4598-13-221","article-title":"A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells","volume":"13","author":"Cheng","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tiv.2024.105920_bb0045","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s11101-017-9495-3","article-title":"Recent advances in the discovery of bioactive metabolites from Pestalotiopsis","volume":"16","author":"Deshmukh","year":"2017","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.tiv.2024.105920_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/srep36860","article-title":"Role of thioredoxin reductase 1 in dysplastic transformation of human breast epithelial cells triggered by chronic oxidative stress","volume":"6","author":"Dong","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2024.105920_bb0055","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.1074\/jbc.M115.700591","article-title":"Targeting thioredoxin reductase by parthenolide contributes to inducing apoptosis of HeLa cells","volume":"291","author":"Duan","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2024.105920_bb0060","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1016\/j.febslet.2011.09.023","article-title":"Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9\/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells","volume":"585","author":"Farina","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tiv.2024.105920_bb0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ncomms1382","article-title":"Crystal structure of the human thioredoxin reductase-thioredoxin complex","volume":"2","author":"Fritz-Wolf","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tiv.2024.105920_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317698368","article-title":"Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer","volume":"39","author":"Gao","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.tiv.2024.105920_bb0075","doi-asserted-by":"crossref","first-page":"10175","DOI":"10.1002\/chem.201905792","article-title":"The thioredoxin system: a promising target for cancer drug development","volume":"26","author":"Ghareeb","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.tiv.2024.105920_bb0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities. Acta Pharmaceutica Sinica B. Chinese Academy of Medical Sciences","volume":"5","author":"Guan","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tiv.2024.105920_bb0085","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3892\/ijo.2016.3469","article-title":"CLDN6-induced apoptosis via regulating ASK1-p38\/JNK signaling in breast cancer MCF-7 cells","volume":"48","author":"Guo","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tiv.2024.105920_bb0090","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3390\/cancers12092392","article-title":"Perspectives on triple-negative breast cancer: current treatment strategies, unmet needs, and potential targets for future therapies","volume":"12","author":"Gupta","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tiv.2024.105920_bb0095","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1038\/sj.onc.1206730","article-title":"p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion","volume":"22","author":"Hayes","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.tiv.2024.105920_bb0100","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.bmc.2012.04.033","article-title":"Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: organoselenium compounds for cancer therapy","volume":"20","author":"He","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tiv.2024.105920_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.586146","article-title":"Novel TrxR1 inhibitors show potential for glioma treatment by suppressing the invasion and sensitizing glioma cells to chemotherapy","volume":"7","author":"Jovanovi\u0107","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tiv.2024.105920_bb0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/md17040241","article-title":"Marine macrolides with antibacterial and\/or antifungal activity","volume":"17","author":"Karpi\u0144ski","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.tiv.2024.105920_bb0115","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10637-018-0704-8","article-title":"The role of oxidative stress in 63 T-induced cytotoxicity against human lung cancer and normal lung fibroblast cell lines","volume":"37","author":"Kucinska","year":"2019","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.tiv.2024.105920_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/1177271918755391","article-title":"Reactive oxygen species: a key constituent in cancer survival","volume":"13","author":"Kumari","year":"2018","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.tiv.2024.105920_bb0125","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.3389\/fimmu.2019.02120","article-title":"Altered cell adhesion, and glycosylation promote cancer immune suppression and metastasis","volume":"10","author":"L\u00e4ubli","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tiv.2024.105920_bb0130","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1089\/ars.2011.4322","article-title":"Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance","volume":"18","author":"Lee","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tiv.2024.105920_bb0135","first-page":"3447","article-title":"Inhibiting TrxR suppresses liver cancer by inducing apoptosis and eliciting potent antitumor immunity","volume":"40","author":"Lei","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tiv.2024.105920_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2597581","article-title":"Oxidative stress gene expression profile correlates with cancer patient poor prognosis: identification of crucial pathways might select novel therapeutic approaches","volume":"2017","author":"Leone","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.tiv.2024.105920_bb0145","first-page":"5865","article-title":"The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis","volume":"14","author":"Li","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tiv.2024.105920_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1915828","article-title":"Isobavachalcone induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in human prostate cancer PC-3 cells","volume":"2018","author":"Li","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.tiv.2024.105920_bb0155","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acs.jnatprod.6b00473","article-title":"Cytotoxic 14-membered macrolides from a mangrove-derived endophytic fungus, Pestalotiopsismicrospora","volume":"79","author":"Liu","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.tiv.2024.105920_bb0160","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1159\/000494874","article-title":"Targeting thioredoxin system with an organosulfur compound, diallyl trisulfide (DATS), attenuates progression and metastasis of triple-negative breast cancer (TNBC)","volume":"50","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.tiv.2024.105920_bb0165","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.3390\/ijms19123999","article-title":"Caspase-3 mediated cell death in the normal development of the mammalian cerebellum","volume":"19","author":"Lossi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2024.105920_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6235641","article-title":"Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy","volume":"2016","author":"Marengo","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.tiv.2024.105920_bb0175","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3390\/ijerph17062078","article-title":"Triple-negative breast cancer: a review of conventional and advanced therapeutic strategies","volume":"17","author":"Medina","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.tiv.2024.105920_bb0180","first-page":"151","article-title":"Epidemiological characteristics of and risk factors for breast cancer in the world","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.tiv.2024.105920_bb0185","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge","volume":"8","author":"Nedeljkovi\u0107","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.tiv.2024.105920_bb0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2018.00245","article-title":"Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tiv.2024.105920_bb0195","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1021\/acs.orglett.8b01894","article-title":"Total synthesis of Pestalotioprolide E and structural revision of Pestalotioprolide F","volume":"20","author":"Paul","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.tiv.2024.105920_bb0200","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tiv.2024.105920_bb0205","article-title":"Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels. Blood Cancer Journal. Nature Publishing Group","volume":"J6","author":"Pillozzi","year":"2016","journal-title":"Blood Cancer"},{"key":"10.1016\/j.tiv.2024.105920_bb0210","doi-asserted-by":"crossref","DOI":"10.1177\/2040206620961712","article-title":"Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond","volume":"28","author":"Poddighe","year":"2020","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.tiv.2024.105920_bb0215","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1093\/jac\/dkw222","article-title":"Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium","volume":"71","author":"Porter","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.tiv.2024.105920_bb0220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/CMAR.S227415","article-title":"Allylated curcumin analog CA6 inhibits TrxR1 and leads to ROS-dependent apoptotic cell death in gastric cancer through Akt-FoxO3a","volume":"12","author":"Rajamanickam","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.tiv.2024.105920_bb0225","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(20)30080-1","article-title":"Immunomodulation by macrolides: therapeutic potential for critical care","volume":"8","author":"Reijnders","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.tiv.2024.105920_bb0230","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1158\/0008-5472.CAN-14-3534","article-title":"Cell-cell adhesion and cytoskeleton tension oppose each other in regulating tumor cell aggregation","volume":"75","author":"Saias","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2024.105920_bb0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/10715762.2015.1108520","article-title":"Phenethyl isothiocyanate, by virtue of its antioxidant activity, inhibits invasiveness and metastatic potential of breast cancer cells: HIF-1\u03b1 as a putative target","volume":"50","author":"Sarkar","year":"2016","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.tiv.2024.105920_bb0240","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.18632\/oncotarget.6828","article-title":"EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells","volume":"7","author":"Shao","year":"2024","journal-title":"Oncotarget"},{"key":"10.1016\/j.tiv.2024.105920_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101400","article-title":"Modification of Cys residues in human thioredoxin-1 by p-benzoquinone causes inhibition of its catalytic activity and activation of the ASK1\/p38-MAPK signalling pathway","volume":"29","author":"Shu","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.tiv.2024.105920_bb0250","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12539-013-0177-6","article-title":"3D QSAR and pharmacophore study of curcuminoids and curcumin analogs: interaction with thioredoxin reductase","volume":"5","author":"Singh","year":"2013","journal-title":"Interdiscip. Sci."},{"key":"10.1016\/j.tiv.2024.105920_bb0255","article-title":"Molecular regulation of cancer cell migration, invasion, and metastasis","volume":"2019","author":"Tahtamouni","year":"2019","journal-title":"Anal. Cell. Pathol. (Amst.)"},{"key":"10.1016\/j.tiv.2024.105920_bb0260","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1083\/jcb.148.1.189","article-title":"Selective uncoupling of p120 ctn from E-cadherin disrupts strong adhesion","volume":"148","author":"Thoreson","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tiv.2024.105920_bb0265","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mnfr.200700492","article-title":"Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy","volume":"53","author":"Tonissen","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.tiv.2024.105920_bb0270","first-page":"106","article-title":"Current approaches in treatment of triple-negative breast cancer","volume":"12","author":"Wahba","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.tiv.2024.105920_bb0275","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.18632\/oncotarget.12284","article-title":"Triple-negative breast cancer: is there a treatment on the horizon?","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tiv.2024.105920_bb0280","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1111\/jcmm.14139","article-title":"Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model","volume":"23","author":"Yin","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tiv.2024.105920_bb0285","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3389\/fonc.2019.00989","article-title":"Cadherin signaling in cancer: its functions and role as a therapeutic target","volume":"9","author":"Yu","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tiv.2024.105920_bb0290","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.tips.2017.06.001","article-title":"Targeting the thioredoxin system for cancer therapy","volume":"38","author":"Zhang","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tiv.2024.105920_bb0295","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/asia.201801136","article-title":"Small molecules to target the selenoprotein thioredoxin reductase","volume":"13","author":"Zhang","year":"2018","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.tiv.2024.105920_bb0300","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3389\/fphar.2019.01180","article-title":"Piperlongumine, a novel TrxR1 inhibitor, induces apoptosis in hepatocellular carcinoma cells by ROS-mediated ER stress","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tiv.2024.105920_bb0305","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/molecules26020315","article-title":"Libertellenone H, a natural pimarane diterpenoid, inhibits thioredoxin system and induces ROS-mediated apoptosis in human pancreatic cancer cells","volume":"26","author":"Zhang","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.tiv.2024.105920_bb0310","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.freeradbiomed.2018.11.030","article-title":"The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen","volume":"131","author":"Zheng","year":"2019","journal-title":"Free Radic. Biol. Med."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233324001504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233324001504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T12:17:47Z","timestamp":1725797867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233324001504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":62,"alternative-id":["S0887233324001504"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2024.105920","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the anticancer potential of Pestalotioprolide E, an unexplored macrolide: Targeting TRXR1-TRX1-ASK1-P38 signaling cascade in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2024.105920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105920"}}